Navigating 6 Analyst Ratings For Dentsply Sirona
Portfolio Pulse from Benzinga Insights
Dentsply Sirona (NASDAQ:XRAY) received mixed analyst ratings, with a decrease in the average 12-month price target from $33.00 to $31.67. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. The company's financials show challenges in revenue growth but strong profitability metrics.
October 08, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Dentsply Sirona's average 12-month price target has decreased by 4.03% to $31.67, reflecting mixed analyst ratings. The company faces revenue growth challenges but maintains strong profitability metrics.
The decrease in the average price target and mixed analyst ratings suggest a neutral short-term impact on XRAY's stock price. While revenue growth is challenged, strong profitability metrics may offset negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100